⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6944961 | 0.84 | KDM4E (0.30) | — | |
| SCHEMBL286913 | 0.78 | TSHR (0.42) | — | |
| SCHEMBL5858279 | 0.71 | GABRP (0.37) | — | |
| SCHEMBL29324533 | 0.71 | — | — | |
| SCHEMBL9430138 | 0.69 | PRKCA (0.36) | — | |
| SCHEMBL2761366 | 0.69 | TSHR (0.38) | — | |
| SCHEMBL194872 | 0.69 | TSHR (0.38) | — | |
| SCHEMBL2915774 | 0.68 | TSHR (0.47) | — | |
| SCHEMBL9396969 | 0.68 | SIRT2 (0.39) | — | |
| SCHEMBL13593724 | 0.68 | CYP1A2 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0587800-B1 | IMMUNOMODULATORY AZASPIRANES | ANORMED INC (CA) | 2003-04-02 | — | — | EP | disclosed |
| EP-0654997-A4 | COMPOSITIONS OF SUBSTITUTED AZASPIRANES AND METHODS OF TREATING PSORIASIS THEREWITH. | SMITHKLINE BEECHAM CORP (US) | 1997-09-17 | — | — | EP | disclosed |
| EP-0771199-A1 | METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-05-07 | — | — | EP | disclosed |
| US-5591748-A | Immunomodulatory azaspiranes | SMITHKLINE BEECHAM CORPORATION (US) | 1997-01-07 | — | — | US | disclosed |
| WO-1996003123-A1 | METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-02-08 | — | — | WO | disclosed |
| US-5455247-A | Methods for the treatment of hyperlipidemia using azaspiranes | SMITHKLINE BEECHAM CORPORATION (US) | 1995-10-03 | — | — | US | disclosed |
| EP-0654997-A1 | COMPOSITIONS OF SUBSTITUTED AZASPIRANES AND METHODS OF TREATING PSORIASIS THEREWITH | SMITHKLINE BEECHAM CORPORATION (US) | 1995-05-31 | — | — | EP | disclosed |
| WO-1995003048-A1 | ANTI-HIV AZASPIRANES | SMITHKLINE BEECHAM CORPORATION (US) | 1995-02-02 | — | — | WO | disclosed |
| WO-1995003046-A1 | A METHOD OF INHIBITING THE PRODUCTION OF HIV | SMITHKLINE BEECHAM CORPORATION (US) | 1995-02-02 | — | — | WO | disclosed |
| WO-1995003047-A1 | HUMAN IMMUNODEFICIENCY VIRUS TREATMENTS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-02-02 | — | — | WO | disclosed |
| EP-0310321-B1 | Immunomodulatory azaspiranes | SMITHKLINE BEECHAM CORP (US) | 1994-11-30 | — | — | EP | disclosed |
| EP-0609335-A4 | METHODS FOR THE TREATMENT OF HYPERLIPIDEMIA USING AZASPIRANES. | SMITHKLINE BEECHAM CORP (US) | 1994-10-12 | — | — | EP | disclosed |
| EP-0609335-A1 | METHODS FOR THE TREATMENT OF HYPERLIPIDEMIA USING AZASPIRANES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-08-10 | — | — | EP | disclosed |
| WO-1994004151-A1 | COMPOSITIONS OF SUBSTITUTED AZASPIRANES AND METHODS OF TREATING PSORIASIS THEREWITH | SMITHKLINE BEECHAM CORPORATION (US) | 1994-03-03 | — | — | WO | disclosed |
| WO-1993015735-A1 | (NON DESCRIPTIVE)-A METHOD FOR DELAYING HIV INDIVIDUAL AIDS BY ADMINISTRATION OF SUBSTITUTED AZASPIRANE COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-08-19 | — | — | WO | disclosed |
| WO-1993007871-A1 | METHODS FOR THE TREATMENT OF HYPERLIPIDEMIA USING AZASPIRANES | SMITHKLINE BEECHAM CORPORATION (US) | 1993-04-29 | — | — | WO | disclosed |
| WO-1992022294-A1 | IMMUNOMODULATORY AZASPIRANES | SMITHKLINE BEECHAM CORPORATION (US) | 1992-12-23 | — | — | WO | disclosed |
| EP-0310321-A2 | Immunomodulatory azaspiranes | SMITHKLINE BEECHAM CORPORATION (US) | 1989-04-05 | — | — | EP | disclosed |